CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Galderma Laboratories, L.P. v. Sun Pharmaceutical Industries Limited

1:16-cv-01003

Overview

Case Number 1:16-cv-01003
Filing Date 2016-10-27
Status Terminated
Termination Date 2019-10-08
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Defendant

Parties

Defendant

Sun Pharmaceutical Industries Limited NPE (University / Research)

Represented By

9 Attorneys Listed

Tiffany Mahmood

Email: tmahmood@goodwinlaw.com

Anjali Moorthly

UNDELIVERABLE EMAIL 6/6/2018

Andrew E. Riley

Email: ariley@goodwinlaw.com

Nicholas K. Mitrokostas

Email: nicholas.mitrokostas@allenovery.com

Kelly E. Farnan

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7705

Richards, Layton & Finger, PA, One Rodney Square

Nicole Kathleen Pedi

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7844
Fax: +1 (302) 498-7701

Richards, Layton & Finger, PA, One Rodney Square

Brian J. Robinson

UNDELIVERABLE EMAIL 7/13/2018

Jeanna Wacker

Email: jeanna.wacker@kirkland.com

Peter B. Silverman

UNDELIVERABLE EMAIL 2/22/17

Sun Pharmaceutical Industries Inc. Operating Company

Represented By

6 Attorneys Listed

Tiffany Mahmood

Email: tmahmood@goodwinlaw.com

Anjali Moorthly

UNDELIVERABLE EMAIL 6/6/2018

Andrew E. Riley

Email: ariley@goodwinlaw.com

Kelly E. Farnan

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7705

Richards, Layton & Finger, PA, One Rodney Square

Nicole Kathleen Pedi

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7844
Fax: +1 (302) 498-7701

Richards, Layton & Finger, PA, One Rodney Square

Huiya Wu

Email: HWu@goodwinlaw.com

Plaintiff

TCD Royalty Sub LLC Operating Company

Represented By

6 Attorneys Listed

Lucas L. Kressel

Email: lucaskressel@paulhastings.com

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Vanessa Y. Yen

Email: vyen@kslaw.com

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Megan Elizabeth Dellinger

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9366

1201 North Market Street, P.O. Box 1347

Galderma Laboratories, L.P. NPE (Individual / Inventor)

Represented By

9 Attorneys Listed

Lucas L. Kressel

Email: lucaskressel@paulhastings.com

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Vanessa Y. Yen

Email: vyen@kslaw.com

Evan D. Diamond

Email: ediamond@kslaw.com

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Megan Elizabeth Dellinger

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9366

1201 North Market Street, P.O. Box 1347

Gerald J. Flattmann , Jr.

Email: gflattmann@kslaw.com

Andrew T. Kessel

Email: andrewkessel@paulhastings.com

Counter Defendant

Nestle Skin Health S.A. Operating Company

Represented By

6 Attorneys Listed

Lucas L. Kressel

Email: lucaskressel@paulhastings.com

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Vanessa Y. Yen

Email: vyen@kslaw.com

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Megan Elizabeth Dellinger

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9366

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 13 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials 4 proceedings
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (13): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (4 found):
PTAB: 4
USPTO PTAB Trial 2015-08-20
IPR2015-01782

Dr. Reddy’s Laboratories, Ltd. et al. v. GALDERMA LABORATORIES, INC. et al.

U.S. Continuation Sibling (8603506)
Status: Institution Denied
USPTO PTAB Trial 2015-08-20
IPR2015-01778

Dr. Reddy’s Laboratories, Ltd. et al. v. GALDERMA LABORATORIES, INC. et al.

U.S. Continuation Sibling (8603506)
Status: Institution Denied
USPTO PTAB Trial 2015-08-20
IPR2015-01777

Dr. Reddy’s Laboratories, Ltd. et al. v. GALDERMA LABORATORIES, INC. et al.

U.S. Continuation Sibling (8603506)
Status: Institution Denied
USPTO PTAB Trial 2013-06-20
IPR2013-00368

Amneal Pharmaceuticals, LLC et al. v. Supernus Pharmaceuticals, Inc. et al.

U.S. Continuation Sibling (8206740)
Status: Final Written Decision
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

10 Patents

There are 10 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7211267
Methods of treating acne
Filed: 2002-04-05
Issued: 2007-05-01
Expired (Term Ended)
Expires: 2022-04-05
US7749532
Once daily formulations of tetracyclines
Filed: 2004-04-07
Issued: 2010-07-06
Active (1.1 yrs remaining) +1351d PTA
Expires: 2027-12-19
US8206740
Once daily formulations of tetracyclines
Filed: 2008-06-06
Issued: 2012-06-26
Expired (Term Ended)
Expires: 2025-12-24
US8394405
Once daily formulations of tetracyclines
Filed: 2010-12-17
Issued: 2013-03-12
Active (4.1 yrs remaining)
Expires: 2030-12-17
US8394406
Once daily formulations of tetracyclines
Filed: 2010-12-17
Issued: 2013-03-12
Active (4.1 yrs remaining)
Expires: 2030-12-17

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

62

Dispositive

0

Granted

1

Denied

0

Pending / Review

49

Motions by Category

Procedural / Extension Motion 27 Claim Construction / Markman Filing 28 Motion to Strike / Sanctions 7

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending
SO ORDERED, re 235 STIPULATION TO EXTEND TIME to submit proposed redactions and support to October 4, 2019 filed by Sun Pharmaceutical Industries Limited, Sun P...
Entry #— • 2019-10-04
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to submit proposed redactions and support to October 4, 2019 - filed by Sun Pharmaceutical Industries Inc., Sun Pharmaceutical Indust...
Entry #235 • 2019-10-03 Document →
Claim Construction / Markman Filing Pending / Under Review
REDACTED VERSION of 227 Claim Construction Opening Brief by Sun Pharmaceutical Industries Inc., Sun Pharmaceutical Industries Limited. (Pedi, Nicole) (Entered: ...
Entry #230 • 2019-09-19 Document →
Claim Construction / Markman Filing Pending / Under Review
REDACTED VERSION of 228 Claim Construction Answering Brief by Sun Pharmaceutical Industries Inc., Sun Pharmaceutical Industries Limited. (Pedi, Nicole) (Entered...
Entry #231 • 2019-09-19 Document →
Claim Construction / Markman Filing Pending / Under Review
[SEALED] CLAIM CONSTRUCTION ANSWERING BRIEF re 226 Claim Construction Opening Brief filed by Sun Pharmaceutical Industries Inc., Sun Pharmaceutical Industries L...
Entry #228 • 2019-09-12 Document →
Claim Construction / Markman Filing Pending / Under Review
[SEALED] CLAIM CONSTRUCTION ANSWERING BRIEF re 227 Claim Construction Opening Brief filed by Galderma Laboratories, L.P., Nestle Skin Health S.A., TCD Royalty S...
Entry #229 • 2019-09-12 Document →

Docket Entries

(359 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Sun Pharmaceutical Industries Inc., Sun Pharmaceutical Industries Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2021036.) - filed by Nestle Skin Health S.A., Galderma Laboratories, L.P., TCD Royalty Sub LLC. (Attachments: # 1 Exhibit A - E, # 2 Exhibit F, # 3 Exhibit G, # 4 Exhibit H - J, # 5 Civil Cover Sheet)(lmm) (Entered: 10/28/2016)

Entry #1 • 2016-10-27
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lmm) (Entered: 10/28/2016)

Entry #2 • 2016-10-27
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/15/2016. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 3/15/2019. (lmm) (Entered: 10/28/2016)

Entry #3 • 2016-10-27
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,211,267 B2; 7,232,572 B2; 8,603,506 B2; 9,241,946 B2; 7,749,532 B2. (lmm) (Entered: 10/28/2016)

Entry #4 • 2016-10-27
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Galderma General, L.L.C., Corporate Parent Nestle Skin Health U.S., Inc. for Galderma Laboratories, L.P. filed by Galderma Laboratories, L.P. (lmm) (Entered: 10/28/2016)

Entry #5 • 2016-10-27
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc